Details of Host Protein
Host Protein General Information (ID: PT0356) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Protein Name |
DNA-directed RNA polymerase II subunit E (POLR2E)
|
Gene Name |
POLR2E
|
||||||
Host Species |
Homo sapiens
|
Uniprot Entry Name |
RPAB1_HUMAN
|
||||||
Protein Families |
Archaeal Rpo5/eukaryotic RPB5 RNA polymerase subunit family
|
||||||||
Subcellular Location |
Nucleus
|
||||||||
External Link | |||||||||
NCBI Gene ID | |||||||||
Uniprot ID | |||||||||
Ensembl ID | |||||||||
HGNC ID | |||||||||
Function in Host |
DNA-dependent RNA polymerase catalyzes the transcription ofDNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesizeribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and small RNAs, such as 5S rRNA and tRNAs, respectively. Pol II is the central component of the basal RNA polymerase IItranscription machinery. Pols are composed of mobile elements that moverelative to each other. In Pol II, POLR2E/RPB5 is part of the lower jawsurrounding the central large cleft and thought to grab the incomingDNA template. Seems to be the major component in this process.
[1]
Click to Show/Hide
|
||||||||
Related KEGG Pathway | |||||||||
Cytosolic DNA-sensing pathway | hsa04623 |
Pathway Map ![]() |
|||||||
RNA polymerase | hsa03020 |
Pathway Map ![]() |
|||||||
Huntington disease | hsa05016 |
Pathway Map ![]() |
|||||||
3D Structure |
|
Full List of Virus RNA Interacting with This Protien | |||||||||
---|---|---|---|---|---|---|---|---|---|
RNA Region: ORF10 (hCoV-19/Not Specified Virus Strain ) | |||||||||
RNA Region Details |
RNA Info
![]() |
[2] | |||||||
Strains Name |
hCoV-19/Not Specified Virus Strain
|
||||||||
RNA Binding Region |
ORF10
|
||||||||
Virus Name |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
||||||||
Infection Cells | Calu-3 cells (Human Lung Cancer Cell) (CVCL_0609 ) | ||||||||
Cell Originated Tissue | Liver | ||||||||
Interaction Score | P-value < 0.05 | ||||||||
Method Description | RNA pull-down assays; liquid chromatography with tandem mass spectrometry (LC-MS/MS); Wilcoxon test; MS2 affinity purification coupled with liquid chromatography-mass spectrometry (MAMS) |